baber/WOPTO huggingface dataset:
Patent CA-2808651-A1 (CA)
Inventor: GOLDMAN DOROTHEE
IPC: G01N21/75
Filed: 2011-08-04
Abstract: A method of determining the phase of an estrous cycle that a mammal is in at a given time that a biological sample is obtained from the mammal is provided. The biological sample obtained from the mammal is combined with at least one flavonoid pigment that reacts with the biological sample on a hydrophobic surface to provide a color response. The estrus phase of the estrous cycle has a corresponding color response that is distinguishable from the color response of each other phase of the estrous cycle to an unaided human eye. The corresponding color response is correlated to the estrus phase of the estrous cycle.
Patent CA-2810596-A1 (CA)
Inventor: HEIDENREICH ERIK
IPC: C02F1/00
Filed: 2013-03-27
Abstract: An antimicrobial filter is disclosed comprising at least two porous media: a first porous medium including silver particles in the bulk of the medium, disposed on a second porous medium suitable for capturing silver particles leached from the first medium.
Patent CA-2812894-A1 (CA)
Inventor: JONES MICHAEL DAVID
IPC: G01B5/24
Filed: 2011-08-02
Abstract: A measuring tool which has a first arm and a second arm where at least one of the arms is able to pivot so that the arms can be set at a variety of angles with respect to one another. The tool also has an angle scale and a pointer. The angle scale runs along the first arm and the pointer is able to pivot so that it can point to a variety of positions along the angle scale to give the angle between the arms, the pointer being arranged such that it can be swung away from and clear of the angle scale.
Patent CA-2814492-A1 (CA)
Title: Procede de fabrication de lait fermente liquide
Inventor: SAITO MASATO
IPC: A23C9/12
Filed: 2011-10-11
Abstract: L'invention concerne un procédé de fabrication de lait fermenté liquide dans lequel il n'y a pas besoin de chauffer le lait après fermentation, d'utiliser des additifs spéciaux ou similaires, et dans lequel il est possible d'amoindrir des augmentations d'acidité ou des diminutions de pH au cours du temps au cours d'un stockage réfrigéré, pour permettre à la flaveur rafraîchissante (goût aigre) provenant de bactéries lactiques de yaourt d'être conservée pendant une longue durée, et de supprimer la production d'acide au cours du stockage pour permettre à une bonne qualité d'être maintenue. Le procédé de fabrication de lait fermenté liquide consiste à utiliser du Lactobacillus et du Lactococcus en tant que bactéries lactiques destinées à être ajoutées à la matière de départ pour le lait fermenté, le procédé comprenant en outre une étape d'homogénéisation pour obtenir le lait fermenté liquide sous une pression d'homogénéisation se situant dans une plage de 50-100 MPa. Le changement d'acidité du lait fermenté liquide résultant après 25 jours est de 0,25 % ou moins lorsque le lait est stocké à une température de 10°C pendant 25 jours après la fin de la fermentation.
Patent CA-2817570-A1 (CA)
Inventor: KOEHLER JEFFREY ALAN
IPC: B01D61/02
Filed: 2011-11-10
Abstract: A process for preparing a reverse osmosis membrane that includes: (A) providing a polyamine, a polyfunctional acid halide, and a flux increasing additive having the formula Z+B-, where Z+ is an easily dissociable cation and B- is a beta-diketonate; (B) combining the polyamine, polyfunctional acid halide, and flux increasing additive on the surface of a porous support membrane; and (C) interfacially polymerizing the polyamine and the polyfunctional acid halide, and flux increasing additive on the surface of the porous support membrane to form a reverse osmosis membrane comprising (i) the porous support membrane and (ii) a discrimination layer comprising a polyamide. The reverse osmosis membrane is characterized by a flux that is greater than the flux of the same membrane prepared in the absence of the flux increasing additive.
Patent CA-2818541-A1 (CA)
Title: System and method for providing secure data communication permissions to trusted applications on a portable communication device
Inventor: BRUDNICKI DAVID
IPC: G06F7/04
Filed: 2011-11-16
Abstract: A system for providing an application associated with a portable communication device the ability to communicate via a secure element. The system has a digital identifier and digital token operably associated with the application; a card services module that provides an application programming interface to the secure element; and a secure data table associated wit the card services module. The secure data table includes a list of trusted applications each identified by paired digital identifier and token and possibly a set of permissions. The card services module compares the identifier and token with each of the identifier-token pairs with a match indicating the application is trusted. The card services module issues commands to the secure element based on the request by a trusted application presenting a digital token. A method is also disclosed. The commands may be issued only if they will not violate the permissions set.
Patent CA-2821370-A1 (CA)
Inventor: YANG DAICHANG
IPC: C07K14/765
Filed: 2011-08-18
Abstract: The present invention provides a method for purifying human serum albumin from transgenic rice grain, which comprises the steps of: 1 ) subjecting crude extract of rHSA to cation exchange chromatography to obtain primary product I; 2) subjecting the primary product I to anion exchange chromatography to obtain secondary product II; 3) subjecting the secondary product II to hydrophobic chromatography to obtain purified rHSA. The method may further comprises a step of ceramic hydroxyapatite chromatography prior to hydrophobic chromatography.
Patent CA-2825612-A1 (CA)
Inventor: ADEY NILS B
IPC: G01N1/10
Filed: 2011-11-16
Abstract: Devices, systems, and associated methods for selectively extracting a material from a sample are provided. In one aspect, for example, a method for selectively extracting biological material from a biological sample can include identifying a region of biological material to be extracted from a biological sample disposed on a substantially planar surface, applying an extraction tool to the region of biological material to disrupt biological material from the biological sample, and dispensing a liquid at the region of biological material. The method can also include aspirating the liquid and the disrupted biological material from the biological sample.
Patent CA-2825659-A1 (CA)
Inventor: MARCOS MUNOZ JUAN JOSE
IPC: A61H5/00
Filed: 2012-03-02
Abstract: Device and method for investigating, diagnosing, or helping to diagnose, and treating functional vision problems, which device is formed by an apparatus which includes functional assemblies (2) intended to be placed in front of the user's eyes, each functional assembly (2) comprising a display-type screen (5), lens-type elements (6), a camera (7) for capturing images and light projection spotlights (8), which functional assemblies (2) are connected to an electronic unit (10) to which are connected, in turn, a computer (11), a system for detecting external variables (12-13), an audio intercommunication system (14-15) and a control means (16), for determining functional vision problems and performing exercises for correcting said problems.
Patent CA-2826289-A1 (CA)
Inventor: DIERICKX WILLIAM
IPC: B29C45/27
Filed: 2012-02-01
Abstract: An injection molding apparatus for manufacturing hollow objects, such as plastic e.g. multi-layered preforms, comprising an injection mold (1) with a front (2) and a rear side (3), which is composed of a clamp plate (4) on the front side (2), and a hot runner plate (5), where a manifold (6) is mounted in the hot runner plate, between which a set of injection nozzles (7) is arranged, which are each provided with a central supply duct (8), at the free end (9) whereof an injection gate (10) is provided. Said apparatus is remarkable in that said injection gate (10) is closable by means of a locking rod (11), which is movable herein to and fro through a profiled inner part (12) which is received in a holder (13) around which a heating element (14) is provided into which a primary channel (15) opens for supplying the plastic base material to the injection gate (10). Each injection nozzle (7) is directly removable individually from the injection side (16) of the injection mold at the injection side thereof, and a respective secondary channel (17) is provided separately; and method therefor.
Patent CA-2829981-A1 (CA)
Title: Surgical staple cartridges and end effectors with vessel measurement arrangements
Inventor: O'CONNOR MEGAN A
IPC: A61B17/072
Filed: 2012-03-13
Abstract: Surgical staple cartridges and end effectors for assessing a size of tissue stapled by the staple cartridge or otherwise manipulated by the end effector. In various forms, the staple cartridge has at least one series of measurement indicia on the deck base that may be viewed from above the deck surface when the anvil is clamping the tissue onto the staple cartridge. Other embodiments include structure for forming a mark on the cartridge deck that corresponds to a size of the tissue supported thereon. Methods for severing and stapling tissue are also disclosed.
Patent CA-2830957-A1 (CA)
Inventor: FARIN DANNY
IPC: A61B1/313
Filed: 2012-03-21
Abstract: L'invention concerne un système visuel pour une laparoscopie, comprenant un dispositif visuel ayant un élément de tête de vision et un connecteur allongé ; un dispositif de manipulation ayant une partie d'actionnement tenue à la main, une partie d'introduction et un premier élément de contact ; et un dispositif externe comprenant des moyens pour communiquer avec l'élément de tête de vision, par l'intermédiaire du premier élément de contact, lorsque le connecteur allongé est monté dans une lumière de la partie d'introduction. La partie d'introduction du dispositif de manipulation est configurée pour pouvoir s'étendre hors d'une cavité corporelle à travers un passage étanche à l'air, ce par quoi le connecteur allongé est configuré pour être monté de façon coulissable dans la lumière de la partie d'introduction à l'extérieur de la cavité corporelle lorsque la partie d'introduction est retirée dans la cavité corporelle.
Patent CA-2833013-A1 (CA)
Inventor: ST JAMES ELLIOT
IPC: G11B20/10
Filed: 2005-03-08
Abstract: A brake assembly comprises a tool plate and a brake dial attached to the tool plate. A hydraulic hose connector connects a hydraulic hose to the brake assembly. A ram housing is operably connected to the hydraulic hose connector. A ram is operably positioned within the ram housing such that the ram is pushed when hydraulic pressure is transmitted along the hydraulic hose. A brake pin, engagable by the ram, secures to engage the brake dial to prevent pivotal movement of the tool plate.
Patent CA-2837525-A1 (CA)
Title: 2-chloroethylphosphonic acid and lanolin composition effective in the control of parasitic or hemiparasitic plants on host plants
Inventor: ANGELES ALVAREZ PEDRO GUILLERMO
IPC: A01N57/12
Filed: 2013-01-15
Abstract: The present invention relates to compositions consisting of: (a) at least one ethylene-releasing compound, and (b) at least one fatty acid ester, alone or in combination with one or more excipients, vehicles or additives, and/or (c) one or more noxious agents. The invention also relates to the use of said composition and to methods for controlling parasitic plants and/or hemiparasitic plants that cause infestations in certain trees. The composition of the invention is characterized in that it exhibits a high degree of adhesion to the parasitic and/or hemiparasitic plant, is selective and acropetal, and has excellent stability and water-impermeability, allowing the prolonged and constant release of ethylene.
Patent CA-2839158-A1 (CA)
Inventor: PATIL NITIN
IPC: A61B5/296
Filed: 2012-04-20
Abstract: Multifunctional guidewire assemblies and system for analyzing anatomical and functional parameters are described. Using a single guidewire, functional and anatomical measurements and identification of lesions may be made. Functional measurements such as pressure may be obtained with a pressure sensor on while anatomical measurements such as luminal dimensions may be obtained by utilizing an electrode. The vascular network and stenosed lesions may be modeled into an equivalent electrical network and solved based on the measured parameters. Treatment plan options may be constructed where each plan may correspond to the treatment of a subset of particular lesions. The anatomical outcome for each treatment plans may be estimated and the equivalent modified electrical parameters may be determined. Then, each of the electrical networks for each plan may be solved to determine the functional outcome for each treatment plan and the outcomes for all treatment plans may be presented to a physician.
Patent CA-2839453-A1 (CA)
Inventor: GHERSIN MURIEL
IPC: A61Q19/02
Filed: 2012-06-27
Abstract: Compositions comprising a moisturizing agent, a desquamating agent, a mattifying agent and an agent that increases skin luminosity are disclosed herein. The compositions are useful for moisturizing, desquamating, mattifying, and increasing the luminosity in skin of an individual having a Fitzpatrick Skin Type IV, V, or VI. Also disclosed are methods for moisturizing, desquamating, mattifying, and increasing the luminosity in skin, comprising administering to an individual having a Fitzpatrick Skin Type IV, V, or VI, the present compositions.
Patent CA-2840129-A1 (CA)
Inventor: LACAL SANJUAN JUAN CARLOS
IPC: A61K33/243
Filed: 2012-06-20
Abstract: The invention relates to the use of choline kinase alpha as predictive marker for the determination of the response to a chemotherapeutic treatment in a subject suffering from cancer, particularly for predicting the clinical response of a subject suffering from non-small cell lung cancer to a platinum-based chemotherapeutic treatment. The invention relates to methods for designing a personalised therapy for subjects suffering from cancer, particularly from non- small cell lung cancer, based on the expression levels of choline kinase alpha as well as to methods for the treatment of non-small cell lung cancer using a platinum-based chemotherapeutic treatment based in a subject wherein the subject is selected based on the expression levels of choline kinase alpha.
Patent CA-2846620-A1 (CA)
Inventor: FORTE DEBORAH
IPC: G06F21/31
Filed: 2012-08-24
Abstract: An e-reader with a password protected supervisory account that controls various features and functions of the e-reader, and e-reader user profile accounts for reading users of the e-reader. The supervisory account permits the supervisor user to set up one or more e-reader user profiles that are each assigned its own customizable bookshelf for displaying the available electronic published content, such as, e-books.
Patent CA-2847633-A1 (CA)
Inventor: SHAH VIMAL V
IPC: H04H60/31
Filed: 2005-07-01
Abstract: Un appareil,  un système et une méthode sont présentés en vue de produire un signal acoustique. Une réalisation de l'appareil comprend une source de signal, un transducteur piézoélectrique servant à produire le signal acoustique à moduler le long dun mandrin et une section servant à coupler la source de signal à un transducteur piézoélectrique. Le transducteur piézoélectrique peut comprendre une extrémité de fond comportant une ou plusieurs languettes électriques. La section peut comporter un ou plusieurs ressorts, où le un ou plusieurs ressorts sont alignés aux une ou plusieurs languettes électriques et où la section et le transducteur piézoélectrique ne sont pas physiquement reliés. Dans une autre réalisation de l'appareil, le transducteur piézoélectrique peut comprendre au moins un élément piézoélectrique et au moins une électrode qui ne comporte pas de joints non permanents. Une réalisation du système peut comprendre le transducteur piézoélectrique.
Patent CA-2849619-A1 (CA)
Title: Device and method for making a dilute aqueous solution of peroxomonosulphuric acid
Inventor: STESEL PETER
IPC: B01J14/00
Filed: 2012-09-19
Abstract: A device, comprising a conduit for an aqueous stream, a mixing tube located inside the conduit, having a static mixer inside the mixing tube, an outlet open to the conduit and an inlet, a sulphuric acid supply tube connected to the inlet of the mixing tube and a hydrogen peroxide supply tube, arranged inside the sulphuric acid supply tube and having an outlet for hydrogen peroxide at the inlet of said mixing tube, and a method, where an aqueous stream is passed through the conduit of the device, 85 to 98 % by weight sulphuric acid is introduced to the sulphuric acid supply tube of the device and 50 to 80 % by weight aqueous hydrogen peroxide solution is introduced to the hydrogen peroxide supply tube of the device, provide a dilute aqueous solution of peroxomonosulphuric acid without a risk of exposing operating personnel to concentrated peroxomonosulphuric acid.
Patent CA-2850693-A1 (CA)
Title: Analytical apparatus for detecting at least one analyte in a sample
Inventor: PETRICH WOLFGANG
IPC: G01N21/64
Filed: 2012-11-12
Abstract: An analytical apparatus (130) is proposed for detecting at least one analyte in a sample (126), in particular for detecting blood glucose, wherein the analytical apparatus (130) is designed to perform at least one analyte measurement, during which analyte measurement at least one changeable property of at least one test chemical (119) of a test element (110) is detected, in particular an electrical and/or optical property, and the analytical apparatus (130) is furthermore designed to conduct at least one quality measurement on the test chemical (119), at least one characteristic luminescence of the test chemical (119) being detected in the quality measurement, and a conclusion being drawn from the characteristic luminescence about the quality of the test chemical (119), especially a degradation.
Patent CA-2850705-A1 (CA)
Title: 2-(phenyl or pyrid-3-yl)aminopyrimidine derivatives as kinase lrrk2 modulators for the treatment of parkinson's disease
Inventor: BAKER-GLENN CHARLES
IPC: C07D417/12
Filed: 2012-11-28
Abstract: Compounds of the formula (I), or pharmaceutically acceptable salts thereof, wherein m, n. X, R1, R2, R3, R4 and R5 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinson's disease.
Patent CA-2851391-A1 (CA)
Inventor: CURLETT JOSHUA
IPC: H05B44/00
Filed: 2013-10-09
Abstract: The invention relates to a portable, skid mounted, wheeled and/or collapsible hybrid-power lighting and energy management system for harsh, remote and/or high latitude locations. The system combines an internal combustion engine (ICE) power source with a control system for providing power to light system. The system may also include a battery storage system, an ICE heating system and/or renewable solar and/or wind power systems in a manner that improves efficiency and reliability of operation in such locations, while preserving and improving functionality of operation and significantly reducing operator interaction during set-up and operation.
Patent CA-2852140-A1 (CA)
Title: A multilevel converter and a method for controlling multilevel converter including balancing cell voltages
Inventor: HASLER JEAN-PHILIPPE
IPC: H02J3/26
Filed: 2011-10-14
Abstract: A multilevel converter and a method for controlling a multilevel converter is provided. The multilevel converter is a single phase converter with one phase leg (1), or a three phase converter with three phase legs (1A-C), the phase legs of the three phase converter are interconnected in a star-configuration. The (1), or each (1A-C), phase leg comprises switching cells (11, 21),and each switching cell (11, 21) comprises semi-conductor switches (41, 51) arranged to selectively provide a connection to a corresponding energy storage element (42, 52). The converter also includes a controller (31), which is provided to monitor the DC voltage (VDC) of the energy storage elements (42, 52), and the controller (31) is provided to control the switching of each switching cell (11, 21). The phase leg (1) of the single phase converter, or each phase leg (1A-C) of the three phase converter, comprises two parallel branches (10, 20) of switching cells (11, 21), the branches (10, 20) being configured in a closed circuit. The method includes monitoring (105) the voltage levels of each of the energy storage elements, and balancing (107) the voltages of the energy storage elements, wherein the balancing includes circulating a current (104, 107) within the two branches of the (1), or each (1A-C), phase leg of the multilevel converter.
Patent CA-2853455-A1 (CA)
Title: Meglumine salt formulations of 1-(5,6-dichloro-1h-benzo[d]imidazol-2-yl)-1h-pyrazole-4-carboxylic acid
Inventor: SEPASSI KIA
IPC: C07D403/04
Filed: 2012-10-25
Abstract: The meglumine salt of 1-(5,6-dichloro-1H-benzo[d]imidazol-2-yl)-1H-pyrazole-4-carboxylic acid (compound (1)) and pharmaceutically acceptable formulations thereof are described. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states, disorders, and conditions mediated by prolyl hydroxylase activity.
Patent CA-2855063-A1 (CA)
Inventor: FRIEDRICHS DANIEL
IPC: A61B18/14
Filed: 2014-06-25
Abstract: An electrosurgical generator is provided. The electrosurgical generator includes at least one converter configured to output a DC waveform and a nonlinear carrier control current. At least one boost inverter is coupled to the at least one converter and is configured to convert the DC waveform to generate at least one electrosurgical waveform. At least one inductor is connected in series with the at least one converter and at least one boost inverter and is configured to output an inductor current. A controller is coupled to the at least one converter and the at least one boost inverter and is configured to maintain the inductor current at a predetermined value by controlling a pulse duration of a duty cycle of the at least one converter based on a comparison of inductor current and the nonlinear control current.
Patent CA-2855787-A1 (CA)
Title: Process for the recovery of betaine from molasses
Inventor: VAN LOO JAN
IPC: A23K10/33
Filed: 2012-11-15
Abstract: The invention relates to a process for the recovery of betaine from a raw material consisting essentially of molasses, comprising: i. a demineralisation step, in which the overall amount of salts in the molasses is brought to a level lying below 2 wt.%  (on overall dry matter); ii. a conversion step, in which the molasses is subjected to the action of a fructan-forming enzyme, to form a fructan-containing molasses (fructan-molasses); iii. a separation step, in which the fructan-molasses is subjected to a chromatographic separation, thereby obtaining a betaine-containing fraction, whereby step (i) is executed prior to step (iii), and whereby step (i) may be executed prior to, during, or subsequent to step (ii). The raw material may alternatively contain or consist essentially of thick juice.
Patent CA-2857128-A1 (CA)
Inventor: JAMIOLKOWSKI DENNIS D
IPC: A61F2/02
Filed: 2012-11-20
Abstract: A novel in vitro methodology for predicting the in vivo behavior, such as absorption time or mechanical strength retention, of biodegradable polymeric implants and medical devices. The present invention provides a novel in vitro methodology, hydrolysis profiling, for studying the degradation of absorbable polymers. Accuracy and reproducibility have been established for selected test conditions. Data from this in vitro method are correlated to in vivo absorption data, allowing for the prediction of accurate in vivo behaviors, such as absorption times.